Article
Insulin-like growth factor-1 endues monocytes with immune suppressive ability to inhibit inflammation in the intestine.
Scientific reports - 15 Jan 2015
Ge Rong-Ti, Mo Li-Hua, Wu Ruijin, Liu Jiang-Qi, Zhang Huan-Ping, Liu Zhigang, Liu Zhanju, Yang Ping-Chang
Abstract excerpt
The pathogenesis of some chronic inflammation such as inflammatory bowel disease is unclear. Insulin-like growth factor-1 (IGF1) has active immune regulatory capability. This study aims to investigate into the mechanism by which IGF1 modulates the monocyte (Mo) properties to inhibit immune inflammation in the intestine. In this study, the production of IGF1 by intestinal epithelial cells was evaluated by real...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
